1. Home
  2. RVLV vs CRNX Comparison

RVLV vs CRNX Comparison

Compare RVLV & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

HOLD

Current Price

$22.90

Market Cap

1.8B

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$37.20

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVLV
CRNX
Founded
2003
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
4.5B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
RVLV
CRNX
Price
$22.90
$37.20
Analyst Decision
Buy
Strong Buy
Analyst Count
13
9
Target Price
$29.75
$74.78
AVG Volume (30 Days)
1.4M
872.2K
Earning Date
05-27-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
24.64
N/A
EPS
0.86
N/A
Revenue
$1,225,682,000.00
$1,039,000.00
Revenue This Year
$10.96
$730.30
Revenue Next Year
$8.01
$179.48
P/E Ratio
$26.52
N/A
Revenue Growth
8.48
N/A
52 Week Low
$16.80
$24.10
52 Week High
$31.68
$57.99

Technical Indicators

Market Signals
Indicator
RVLV
CRNX
Relative Strength Index (RSI) 37.52 28.54
Support Level $20.05 $33.23
Resistance Level $24.54 $45.32
Average True Range (ATR) 1.31 1.82
MACD -0.07 -0.21
Stochastic Oscillator 17.44 19.55

Price Performance

Historical Comparison
RVLV
CRNX

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: